Heptares Therapeutics Company

Heptares Therapeutics is a drug discovery company focused on novel small-molecule drugs targeting G-protein-coupled receptors (GPCRs), the largest family of druggable targets.
The Company has developed a unique, transformational and proprietary technology for making purified, stabilised and functional GPCRs (known as StaRs, Stabilised Receptors), overcoming a major limiting factor to the development of new drugs targeting this group.
Technology: Personalized Medicine
Industry: Personalized Medicine
Headquarters: Welwyn Garden City, Hertford, United Kingdom
Founded Date: 2007
Employees Number: 11-50
Funding Status: M&A

Visit Website
Register and Claim Ownership